EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Bausch Health's enterprise value is $23,317 Mil.
Bausch Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2022 was $2,936 Mil. Therefore, Bausch Health's EV-to-EBITDA for today is 7.94.
The historical rank and industry rank for Bausch Health's EV-to-EBITDA or its related term are showing as below:
BHC'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.97 Med: 19.71 Max: 195.04
Current: 7.98
During the past 13 years, the highest EV-to-EBITDA of Bausch Health was 195.04. The lowest was 7.97. And the median was 19.71.
BHC's EV-to-EBITDA is ranked better than 70.86% of 707
companies
in the Drug Manufacturers industry
Industry Median: 12.99
vs BHC: 7.98
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2022-08-18), Bausch Health's stock price is $5.75.
Bausch Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 was $0.120. Therefore, Bausch Health's PE Ratio for today is 47.92.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Bausch Health EV-to-EBITDA Historical Data
The historical data trend for Bausch Health's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Bausch Health Annual Data
Trend
Dec12
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
EV-to-EBITDA
10.81
86.40
17.91
12.67
16.35
Bausch Health Quarterly Data
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
EV-to-EBITDA
20.04
19.36
16.35
12.50
8.61
Competitive Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bausch Health EV-to-EBITDA Distribution
For the Drug Manufacturers industry and Healthcare sector, Bausch Health's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Bausch Health's EV-to-EBITDA falls into.
Bausch Health EV-to-EBITDA Calculation
Bausch Health's EV-to-EBITDA for today is calculated as:
Bausch Health's current Enterprise Value is $23,317 Mil.
Bausch Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,936 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bausch Health (NYSE:BHC) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Bausch Health's PE Ratio for today is calculated as:
Bausch Health's share price for today is $5.75.
Bausch Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.120.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Bausch Health's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Bausch Health Companies Inc develop, manufacture and market, primarily in the therapeutic areas of eye-health, gastroenterology and dermatology, a broad range of branded pharmaceuticals, generic and branded generic pharmaceuticals, over-the-counter products and medical devices, which are marketed directly or indirectly in approximately 100 countries. The company's business segments are Bausch + Lomb, Salix, International Rx, Ortho Dermatologics and Diversified Products with maximum revenue from Bausch + Lomb segment.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0.19(3.2%) Volume: 4,015,899 4:00PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NYSE:BHC has been successfully added to your 
